ADNRX Performance — American Beacon ARK Transformational Innovation Fund, R6 Class
Data updated: 2026-09-28
ADNRX returned +6.70% year to date and +17.02% over one year to Jun 2026. Annualised returns are +23.31% over 3 years and −7.80% over 5 years. The fund beat its Thematic Equity category average: $100 invested three years ago grew to $188, against $161 for the category, and to $117 over one year, against $115. Volatility over the past three years was 39.76% a year. In the 12 months to Jun 2026 the fund lost a net $74.0M, and assets reached $160.02M.
ADNRX Growth of $100
What $100 invested in American Beacon ARK Transformational Innovation Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Thematic Equity category average over the same months.
| Period | ADNRX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $117 | $115 |
| 3 years (Jul 2023 – Jun 2026) | $188 | $161 |
| 5 years (Jul 2021 – Jun 2026) | $67 | $141 |
| Since data start (Oct 2020 – Jun 2026) | $93 | $187 |
ADNRX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +6.70% |
| 1 year | +17.02% |
| 3 years (annualised) | +23.31% |
| 5 years (annualised) | −7.80% |
ADNRX Annual Returns
Calendar-year total returns of American Beacon ARK Transformational Innovation Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +6.70% |
| 2025 | +36.05% |
| 2024 | +8.57% |
| 2023 | +67.99% |
| 2022 | −66.12% |
| 2021 | −22.57% |
| 2020 (Oct–Dec) | +33.75% |
ADNRX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −2.6% | −2.4% | −7.2% | +12.7% | +8.4% | −0.9% | — | — | — | — | — | — |
| 2025 | +10.7% | −11.3% | −14.4% | +7.0% | +10.5% | +24.7% | +6.8% | −0.1% | +11.3% | +5.6% | −9.5% | −3.4% |
| 2024 | −13.2% | +12.1% | −2.2% | −12.7% | −2.4% | +3.6% | +3.4% | −1.3% | +6.1% | −3.4% | +26.0% | −2.0% |
| 2023 | +27.6% | −0.7% | +2.3% | −10.8% | +12.2% | +8.9% | +14.2% | −13.0% | −9.6% | −11.2% | +31.1% | +13.8% |
| 2022 | −20.1% | −6.6% | −5.6% | −28.3% | −6.2% | −9.8% | +10.8% | −6.2% | −9.6% | +2.4% | −2.0% | −16.0% |
| 2021 | +8.3% | −3.3% | −7.9% | +1.1% | −7.3% | +15.2% | −7.4% | +1.9% | −8.3% | +9.9% | −13.1% | −10.2% |
| 2020 | — | — | — | — | — | — | — | — | — | −0.3% | +21.8% | +10.1% |
ADNRX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 39.76%
- 3-year Sharpe ratio: 0.47 (vs 4.5% risk-free rate)
- Best month: +31.05% (Nov 2023)
- Worst month: −14.37% (Mar 2025)
ADNRX Fund Flows
Monthly money in and out of American Beacon ARK Transformational Innovation Fund, from SEC Form N-PORT.
- 12-month net flow: −$74.0M
- 12-month gross sales (incl. reinvestments): $40.4M
- Sales ÷ redemptions: 0.35×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $963K | $15.2M | −$14.2M |
| May 2026 | $1.6M | $10.7M | −$9.1M |
| Apr 2026 | $1.8M | $6.6M | −$4.8M |
| Mar 2026 | $1.7M | $5.9M | −$4.2M |
| Feb 2026 | $2.0M | $6.6M | −$4.6M |
| Jan 2026 | $2.9M | $11.6M | −$8.7M |
| Dec 2025 | $2.5M | $6.8M | −$4.4M |
| Nov 2025 | $4.0M | $9.1M | −$5.1M |
| Oct 2025 | $7.6M | $13.6M | −$6.0M |
| Sep 2025 | $4.5M | $12.6M | −$8.1M |
| Aug 2025 | $4.5M | $7.0M | −$2.5M |
| Jul 2025 | $6.1M | $8.6M | −$2.5M |
ADNRX Assets Under Management
Net assets of American Beacon ARK Transformational Innovation Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $160.02M |
| 2026-03-31 | $156.87M |
| 2025-12-31 | $195.85M |
| 2025-09-30 | $227.81M |
| 2025-06-30 | $203.75M |
| 2025-03-31 | $152.24M |
| 2024-12-31 | $188.48M |
| 2024-09-30 | $191.13M |
| 2024-06-30 | $199.07M |
| 2024-03-31 | $267.26M |
| 2023-12-31 | $308.97M |
| 2023-09-30 | $239.17M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.